• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

口腔鳞状细胞癌患者术后前 3 周错过放疗会预测远处转移和预后不良。

Missed radiation therapy sessions in first three weeks predict distant metastasis and less favorable outcomes in surgically treated patients with oral cavity squamous cell carcinoma.

机构信息

Department of Radiation Oncology, Proton and Radiation Therapy Center, Linkou Chang Gung Memorial Hospital and Chang Gung University, Taoyuan City, Taiwan.

Department of Otolaryngology-Head Neck Surgery, Linkou Chang Gung Memorial Hospital and Chang Gung University, Taoyuan City, Taiwan.

出版信息

Radiat Oncol. 2020 Aug 14;15(1):194. doi: 10.1186/s13014-020-01632-1.

DOI:10.1186/s13014-020-01632-1
PMID:32795324
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7427928/
Abstract

BACKGROUND

We sought to investigate the prognostic impact of missed RT sessions in patients who had undergone surgery for oral cavity squamous cell carcinoma (OCSCC).

METHODS

The study sample consisted of 905 patients with surgically treated OCSCC who fulfilled criteria of RT course ≤8 weeks. The study participants were divided into three groups based on the characteristics of missed RT, as follows: 1) early missed RT, 2) late missed RT, and 3) RT as scheduled.

RESULTS

The 5-year overall survival (OS) rates in the early missed RT, late missed RT, and RT as scheduled groups were 53.0, 58.1, and 64.5%, respectively (p = 0.046). In multivariate analysis, early missed RT was independently associated with both OS (hazard ratio (HR) = 1.486; 95% confidence interval (CI): 1.122-1.966; p = 0.006) and the occurrence of distant metastasis (HR = 1.644; 95% CI: 1.047-2.583; p = 0.031).

CONCLUSION

Early missed RT was independently associated with a higher occurrence of distant metastasis and less favorable OS in patients who had undergone surgery for OCSCC.

摘要

背景

我们旨在研究接受口腔鳞状细胞癌(OCSCC)手术治疗的患者中错过放疗(RT)次数对预后的影响。

方法

研究样本包括 905 名接受过手术治疗且满足 RT 疗程≤8 周标准的 OCSCC 患者。研究参与者根据错过 RT 的特征分为三组:1)早期错过 RT,2)晚期错过 RT,和 3)按时 RT。

结果

早期错过 RT、晚期错过 RT 和按时 RT 组的 5 年总生存率(OS)分别为 53.0%、58.1%和 64.5%(p=0.046)。多变量分析显示,早期错过 RT 与 OS(风险比(HR)=1.486;95%置信区间(CI):1.122-1.966;p=0.006)和远处转移的发生(HR=1.644;95%CI:1.047-2.583;p=0.031)均独立相关。

结论

对于接受 OCSCC 手术治疗的患者,早期错过 RT 与远处转移发生率更高和 OS 更差独立相关。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fdbc/7427928/44a00e2a8525/13014_2020_1632_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fdbc/7427928/44a00e2a8525/13014_2020_1632_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fdbc/7427928/44a00e2a8525/13014_2020_1632_Fig1_HTML.jpg

相似文献

1
Missed radiation therapy sessions in first three weeks predict distant metastasis and less favorable outcomes in surgically treated patients with oral cavity squamous cell carcinoma.口腔鳞状细胞癌患者术后前 3 周错过放疗会预测远处转移和预后不良。
Radiat Oncol. 2020 Aug 14;15(1):194. doi: 10.1186/s13014-020-01632-1.
2
Long-term outcomes in oral cavity squamous cell carcinoma with adjuvant and salvage radiotherapy after surgery.口腔鳞状细胞癌术后辅助放疗和挽救性放疗的长期预后
Laryngoscope. 2018 Nov;128(11):2539-2545. doi: 10.1002/lary.27191. Epub 2018 Apr 10.
3
Identification of a high-risk subgroup of patients with resected pT3 oral cavity cancer in need of postoperative adjuvant therapy.识别接受手术切除的 pT3 口腔癌患者中需要术后辅助治疗的高危亚组。
Ann Surg Oncol. 2011 Sep;18(9):2569-78. doi: 10.1245/s10434-011-1616-4. Epub 2011 Mar 1.
4
Postoperative intensity-modulated radiotherapy following surgery for oral cavity squamous cell carcinoma: patterns of failure.口腔鳞状细胞癌术后调强放疗:失败模式。
Oral Oncol. 2013 Mar;49(3):255-60. doi: 10.1016/j.oraloncology.2012.09.006. Epub 2012 Oct 15.
5
Association Between Lymph Node Ratio and Recurrence and Survival Outcomes in Patients With Oral Cavity Cancer.淋巴结比率与口腔癌患者复发和生存结局的关系。
JAMA Otolaryngol Head Neck Surg. 2019 Jan 1;145(1):53-61. doi: 10.1001/jamaoto.2018.2974.
6
Estimating Survival After Salvage Surgery for Recurrent Oral Cavity Cancer.复发性口腔癌挽救性手术后的生存情况评估。
JAMA Otolaryngol Head Neck Surg. 2017 Jul 1;143(7):685-690. doi: 10.1001/jamaoto.2017.0001.
7
Adjuvant radiotherapy is not supported in patients with verrucous carcinoma of the oral cavity.口腔疣状癌患者不支持辅助放疗。
Laryngoscope. 2017 Jun;127(6):1334-1338. doi: 10.1002/lary.26443. Epub 2017 Feb 1.
8
Improved outcomes in adjuvant radiotherapy for oral cavity carcinoma at an academic center: a matched-pair analysis.学术中心口腔癌辅助放疗的疗效改善:配对分析
Laryngoscope. 2014 Jul;124(7):1603-8. doi: 10.1002/lary.24552. Epub 2014 Feb 6.
9
Prognostic significance of the preoperative systemic immune-inflammation index in patients with oral cavity squamous cell carcinoma treated with curative surgery and adjuvant therapy.术前全身免疫炎症指数对接受根治性手术和辅助治疗的口腔鳞状细胞癌患者的预后意义。
Cancer Med. 2021 Jan;10(2):649-658. doi: 10.1002/cam4.3650. Epub 2020 Dec 16.
10
Primary Surgery vs Radiotherapy for Early Stage Oral Cavity Cancer.早期口腔癌的根治性手术与放疗比较。
Otolaryngol Head Neck Surg. 2018 Apr;158(4):649-659. doi: 10.1177/0194599817746909. Epub 2017 Dec 19.

引用本文的文献

1
Factors Associated With Early Discontinuation of Radiation Therapy: An Analysis of the National Cancer Database.与放射治疗早期中断相关的因素:一项基于国家癌症数据库的分析
Adv Radiat Oncol. 2025 Apr 6;10(6):101784. doi: 10.1016/j.adro.2025.101784. eCollection 2025 Jun.
2
Cisplatin Carboplatin and Paclitaxel in Radiochemotherapy for Patients With Locally Advanced Head and Neck Squamous Cell Carcinoma.顺铂、卡铂和紫杉醇在局部晚期头颈部鳞状细胞癌放化疗中的应用。
In Vivo. 2022 Mar-Apr;36(2):821-832. doi: 10.21873/invivo.12769.

本文引用的文献

1
Treatment package time predicts cancer-specific survival and distant metastasis in laryngeal cancer.治疗方案时间可预测喉癌患者的癌症特异性生存率和远处转移情况。
Oncol Lett. 2019 Jan;17(1):1384-1390. doi: 10.3892/ol.2018.9664. Epub 2018 Nov 5.
2
Survival impact of radiotherapy interruption in nasopharyngeal carcinoma in the intensity-modulated radiotherapy era: A big-data intelligence platform-based analysis.调强放疗时代鼻咽癌放疗中断对生存的影响:基于大数据智能平台的分析。
Radiother Oncol. 2019 Mar;132:178-187. doi: 10.1016/j.radonc.2018.10.018. Epub 2018 Nov 14.
3
Pathological risk factors stratification in pN3b oral cavity squamous cell carcinoma: Focus on the number of positive nodes and extranodal extension.
口腔鳞状细胞癌 pN3b 患者的病理危险因素分层:重点关注阳性淋巴结数量和淋巴结外侵犯。
Oral Oncol. 2018 Nov;86:188-194. doi: 10.1016/j.oraloncology.2018.09.021. Epub 2018 Sep 28.
4
Association of Treatment Delays With Survival for Patients With Head and Neck Cancer: A Systematic Review.治疗延迟与头颈部癌症患者生存的关系:系统评价。
JAMA Otolaryngol Head Neck Surg. 2019 Feb 1;145(2):166-177. doi: 10.1001/jamaoto.2018.2716.
5
Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries.全球癌症统计数据 2018:GLOBOCAN 对全球 185 个国家/地区 36 种癌症的发病率和死亡率的估计。
CA Cancer J Clin. 2018 Nov;68(6):394-424. doi: 10.3322/caac.21492. Epub 2018 Sep 12.
6
IL-1β inflammatory response driven by primary breast cancer prevents metastasis-initiating cell colonization.原发性乳腺癌驱动的 IL-1β 炎症反应可阻止转移起始细胞定植。
Nat Cell Biol. 2018 Sep;20(9):1084-1097. doi: 10.1038/s41556-018-0173-5. Epub 2018 Aug 27.
7
Effects of radiation on the metastatic process.辐射对转移过程的影响。
Mol Med. 2018 Apr 24;24(1):16. doi: 10.1186/s10020-018-0015-8.
8
Adjuvant radiotherapy after curative surgery for oral cavity squamous cell carcinoma and treatment effect of timing and duration on outcome-A Taiwan Cancer Registry national database analysis.口腔鳞状细胞癌根治性手术后的辅助放疗以及放疗时机和持续时间对预后的治疗效果——一项台湾癌症登记处全国数据库分析
Cancer Med. 2018 Jul;7(7):3073-3083. doi: 10.1002/cam4.1611. Epub 2018 Jun 14.
9
Premature discontinuation of curative radiation therapy: Insights from head and neck irradiation.根治性放射治疗的提前中断:头颈部放疗的见解
Adv Radiat Oncol. 2017 Oct 23;3(1):62-69. doi: 10.1016/j.adro.2017.10.006. eCollection 2018 Jan-Mar.
10
Association of Survival With Shorter Time to Radiation Therapy After Surgery for US Patients With Head and Neck Cancer.美国头颈部癌症患者手术后接受放疗的时间与生存的关系。
JAMA Otolaryngol Head Neck Surg. 2018 Apr 1;144(4):349-359. doi: 10.1001/jamaoto.2017.3406.